Kleber Miranda

Amyi é uma marca de perfumaria nicho direct-to-consumer (DNVB) que nasceu para proporcionar escolhas olfativas conscientes e transformar a perfumaria no Brasil, com inovação, liberdade criativa, conhecimento e descobertas. Estamos aqui para ensinar as pessoas a explorar a arte da perfumaria com confiança, através de uma experiência altamente educativa e sensorial. Proporcionamos total liberdade criativa para nossos perfumistas criarem verdadeiras obras de arte com os melhores ingredientes do mundo. Um caminho colaborativo baseado em sentimento e afeto, onde as percepções sobre cada perfume são compartilhadas com nossos perfumistas para, juntos, elevarmos a inovação da alta perfumaria no Brasil.

ReMederi aims to connect, inform and educate the community with need and interest in the Medicinal Cannabis world, Primary and Integrative Medicine, providing health and well-being to the population. ReMederi works connecting people, companies and purposes, with an operation focused on the world of medical cannabis and essential oils.

MKM Biotech is a forward-thinking investment company with a laser focus on biotechnology and the development of innovative therapies to combat aggressive diseases, particularly in oncology. Our mission is to foster the discovery of new molecules and support transformative biotech startups with the potential to revolutionize healthcare. At MKM, our core values are innovation, persistence, and creating meaningful impact through science. As we look toward the future, we remain committed to driving breakthroughs in healthcare by supporting groundbreaking research and fostering partnerships with scientists, entrepreneurs, and institutions globally. For inquiries or to learn more about opportunities to participate with us, visit our website: http://mkmbiotech.com #InnovationInBiotech #HealthcareRevolution #BiotechInvestments #CancerResearch #MKMOne #FutureOfHealthcare

Após o desenvolvimento de uma molécula com comprovada ação antitumoral com vários testes realizados, nasceu a PHP Biotech com foco exclusivo no desenvolvimento de um medicamento para o tratamento de câncer de Mama do tipo triplo negativo. A empresa foi fundada durante o “outubro rosa” DE 2020. Fruto de Uma parceria entre a Kaivo Biotech, empresa nacional de pesquisa e desenvolvimento de produtos biológicos inovadores, a FCJ Venture Builder, e da junção de uma equipe com mais de 20 anos de atuação na área de P&D e Industria Farmacêutica.

PHP Biotech is a US-based biotech company founded by innovative healthcare entrepreneurs and powered by a world-class scientific team specializing in nanobody and translational biotechnology. ​ Our lead candidate, PHP53-nb, is a first-in-class humanized nanobody showing strong anti-tumor efficacy, low toxicity, and a novel mechanism of action. ​ With positive data in triple negative breast cancer models and potential for many other cancer types carrying TP53 mutations, there is strong potential as both a stand-alone and add-on therapeutic. The platform can be leveraged for many applications including other oncology targets, immunology and more.

Amyi é uma marca de perfumaria nicho direct-to-consumer (DNVB) que nasceu para proporcionar escolhas olfativas conscientes e transformar a perfumaria no Brasil, com inovação, liberdade criativa, conhecimento e descobertas. Estamos aqui para ensinar as pessoas a explorar a arte da perfumaria com confiança, através de uma experiência altamente educativa e sensorial. Proporcionamos total liberdade criativa para nossos perfumistas criarem verdadeiras obras de arte com os melhores ingredientes do mundo. Um caminho colaborativo baseado em sentimento e afeto, onde as percepções sobre cada perfume são compartilhadas com nossos perfumistas para, juntos, elevarmos a inovação da alta perfumaria no Brasil.

ReMederi aims to connect, inform and educate the community with need and interest in the Medicinal Cannabis world, Primary and Integrative Medicine, providing health and well-being to the population. ReMederi works connecting people, companies and purposes, with an operation focused on the world of medical cannabis and essential oils.

MKM Biotech is a forward-thinking investment company with a laser focus on biotechnology and the development of innovative therapies to combat aggressive diseases, particularly in oncology. Our mission is to foster the discovery of new molecules and support transformative biotech startups with the potential to revolutionize healthcare. At MKM, our core values are innovation, persistence, and creating meaningful impact through science. As we look toward the future, we remain committed to driving breakthroughs in healthcare by supporting groundbreaking research and fostering partnerships with scientists, entrepreneurs, and institutions globally. For inquiries or to learn more about opportunities to participate with us, visit our website: http://mkmbiotech.com #InnovationInBiotech #HealthcareRevolution #BiotechInvestments #CancerResearch #MKMOne #FutureOfHealthcare

Após o desenvolvimento de uma molécula com comprovada ação antitumoral com vários testes realizados, nasceu a PHP Biotech com foco exclusivo no desenvolvimento de um medicamento para o tratamento de câncer de Mama do tipo triplo negativo. A empresa foi fundada durante o “outubro rosa” DE 2020. Fruto de Uma parceria entre a Kaivo Biotech, empresa nacional de pesquisa e desenvolvimento de produtos biológicos inovadores, a FCJ Venture Builder, e da junção de uma equipe com mais de 20 anos de atuação na área de P&D e Industria Farmacêutica.

PHP Biotech is a US-based biotech company founded by innovative healthcare entrepreneurs and powered by a world-class scientific team specializing in nanobody and translational biotechnology. ​ Our lead candidate, PHP53-nb, is a first-in-class humanized nanobody showing strong anti-tumor efficacy, low toxicity, and a novel mechanism of action. ​ With positive data in triple negative breast cancer models and potential for many other cancer types carrying TP53 mutations, there is strong potential as both a stand-alone and add-on therapeutic. The platform can be leveraged for many applications including other oncology targets, immunology and more.